Investors

Investors arrow
Print E-mail

Peregrine Pharmaceuticals, Inc.

Corporate and Media Relations

Investors

14282 Franklin Avenue,
Tustin, CA 92780
Phone: 714-508-6000
Fax: 714-838-5817

Linda Donaldson
14282 Franklin Avenue
Tustin, CA 92780

Tel: 714-508-6067
Fax: 714-838-5817
pr@peregrineinc.com

GendeLLindheim BioCom Partners, LLC
Barbara Lindheim
48 Wall Street, Suite 1100
New York, NY 10005 

Tel: 212-918-4949
Tel: 800-987-8256


Featured Event  
Jul 14, 2009 at 11:30 AM ET
Fiscal Year 2009 Financial Results Conference Call


Recent Press Releases  
Jul 2, 2009
Peregrine Pharmaceuticals to Report Fiscal Year 2009 Financial Results
Jul 1, 2009
Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine

View all releases »

Upcoming Events  
Jul 14, 2009 at 11:30 AM ET
Fiscal Year 2009 Financial Results Conference Call

View all events & presentations »

Stock Information  
NASDAQ:PPHM
$0.84   + 0.02
Jul 2, 2009
4:10 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Shareholder Tools  
 
 
© 2003/2009 Peregrine Pharmaceuticals Inc., All Rights Reserved   Disclaimer | Safe Harbor